See more : Deep Well Oil & Gas, Inc. (DWOG) Income Statement Analysis – Financial Results
Complete financial analysis of Deltex Medical Group plc (DTXMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Deltex Medical Group plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- TYK Medicines Inc (2410.HK) Income Statement Analysis – Financial Results
- Turtle Beach Corporation (HEAR) Income Statement Analysis – Financial Results
- Seadrill Limited (SDRLF) Income Statement Analysis – Financial Results
- Sunflex Tech Co., Ltd. (3390.TWO) Income Statement Analysis – Financial Results
- Bangkok Aviation Fuel Services Public Company Limited (BAFS.BK) Income Statement Analysis – Financial Results
Deltex Medical Group plc (DTXMF)
About Deltex Medical Group plc
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.78M | 2.48M | 2.26M | 2.40M | 4.26M | 4.96M | 5.87M | 6.33M | 6.41M | 6.51M | 7.15M | 6.78M | 6.30M | 6.28M | 5.64M | 5.24M | 4.17M | 3.51M | 3.04M | 2.49M | 3.08M | 1.80M | 1.30M | 1.00M | 801.00K | 378.00K |
Cost of Revenue | 651.00K | 643.00K | 684.00K | 757.00K | 974.00K | 1.42M | 1.49M | 2.00M | 2.40M | 1.96M | 1.98M | 1.96M | 1.77M | 1.64M | 1.41M | 1.48M | 1.25M | 1.18M | 1.08M | 907.00K | 1.22M | 900.00K | 700.00K | 500.00K | 555.00K | 402.00K |
Gross Profit | 1.13M | 1.84M | 1.58M | 1.64M | 3.28M | 3.53M | 4.38M | 4.33M | 4.01M | 4.55M | 5.17M | 4.81M | 4.54M | 4.64M | 4.23M | 3.76M | 2.92M | 2.33M | 1.97M | 1.59M | 1.86M | 900.00K | 600.00K | 500.00K | 246.00K | -24.00K |
Gross Profit Ratio | 63.34% | 74.09% | 69.72% | 68.43% | 77.11% | 71.26% | 74.65% | 68.38% | 62.61% | 69.86% | 72.28% | 71.02% | 72.00% | 73.93% | 74.93% | 71.82% | 70.01% | 66.33% | 64.63% | 63.63% | 60.38% | 50.00% | 46.15% | 50.00% | 30.71% | -6.35% |
Research & Development | 217.00K | 231.00K | 207.00K | 246.00K | 446.00K | 526.00K | 558.00K | 464.00K | 807.00K | 1.14M | 1.18M | 553.00K | 396.00K | 282.00K | 255.00K | 394.00K | 282.00K | 241.00K | 361.00K | 488.00K | 420.00K | 400.00K | 200.00K | 400.00K | 302.00K | 299.00K |
General & Administrative | 1.08M | 1.56M | 1.59M | 1.47M | 1.52M | 1.72M | 2.07M | 2.20M | 2.50M | 2.46M | 2.15M | 2.24M | -1.71M | -1.15M | -706.00K | -586.00K | -191.00K | -270.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 685.00K | 1.03M | 957.00K | 964.00K | 1.22M | 2.19M | 3.69M | 4.04M | 4.04M | 3.94M | 3.94M | 4.10M | 3.53M | 3.37M | 3.07M | 3.25M | 2.53M | 2.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.77M | 2.59M | 2.54M | 2.44M | 2.74M | 3.91M | 5.76M | 6.23M | 6.54M | 6.40M | 6.09M | 6.34M | 1.82M | 2.21M | 2.36M | 2.67M | 2.33M | 1.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 194.00K | 71.00K | 57.00K | 171.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -29.00K | -100.00K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 2.18M | 2.82M | 2.44M | 2.21M | 3.18M | 4.44M | 6.32M | 6.70M | 7.34M | 7.54M | 7.27M | 6.89M | 5.95M | 5.97M | 5.69M | 6.31M | 5.14M | 4.28M | 3.74M | 4.37M | 4.29M | 4.10M | 4.00M | 3.80M | 3.09M | 2.08M |
Cost & Expenses | 2.83M | 3.46M | 3.12M | 2.97M | 4.16M | 5.86M | 7.81M | 8.70M | 9.74M | 9.50M | 9.25M | 8.86M | 7.71M | 7.61M | 7.10M | 7.79M | 6.39M | 5.46M | 4.82M | 5.28M | 5.51M | 5.00M | 4.70M | 4.30M | 3.65M | 2.48M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 1.00K | 2.00K | 1.00K | 1.00K | 1.00K | 1.00K | 2.00K | 13.00K | 33.00K | 8.00K | 3.00K | 15.00K | 31.00K | 100.00K | 100.00K | 200.00K | 17.00K | 88.00K |
Interest Expense | 230.00K | 199.00K | 173.00K | 172.00K | 176.00K | 188.00K | 163.00K | 150.00K | 110.00K | 107.00K | 120.00K | 118.00K | 123.00K | 161.00K | 114.00K | 22.00K | 21.00K | 11.00K | 0.00 | 1.00K | 2.00K | 3.00K | 0.00 | 100.00K | 55.00K | 78.00K |
Depreciation & Amortization | 133.00K | 128.00K | 114.00K | 143.00K | 233.00K | 419.00K | 460.00K | 425.00K | 404.00K | 420.00K | 326.00K | 297.00K | 191.00K | 153.00K | 95.00K | 236.00K | 40.00K | 51.00K | 66.00K | 79.00K | 186.00K | 300.00K | 400.00K | 300.00K | 240.00K | 60.00K |
EBITDA | -919.00K | -819.00K | -691.00K | -480.00K | 196.00K | -740.00K | -1.49M | -1.96M | -3.09M | -2.59M | -1.80M | -1.78M | -1.22M | -1.22M | -1.93M | -2.48M | -2.15M | -1.96M | -1.71M | -2.71M | -2.24M | -2.80M | -3.00M | -3.50M | -2.59M | -2.56M |
EBITDA Ratio | -51.75% | -31.43% | -30.59% | -17.89% | 7.85% | -9.81% | -25.18% | -30.69% | -45.71% | -39.47% | -24.77% | -26.27% | -19.31% | -18.65% | -24.22% | -44.03% | -51.61% | -53.92% | -56.05% | -108.58% | -72.60% | -155.56% | -230.77% | -280.00% | -322.97% | -517.20% |
Operating Income | -1.05M | -947.00K | -805.00K | -622.00K | -34.00K | -1.15M | -1.94M | -2.37M | -3.49M | -2.99M | -2.10M | -2.08M | -1.40M | -1.35M | -2.02M | -2.55M | -2.22M | -2.01M | -1.77M | -2.79M | -2.43M | -3.20M | -3.40M | -4.00M | -2.84M | -2.71M |
Operating Income Ratio | -59.23% | -38.15% | -35.64% | -25.94% | -0.80% | -23.21% | -33.02% | -37.42% | -54.43% | -45.95% | -29.34% | -30.66% | -22.24% | -21.55% | -35.78% | -48.79% | -53.33% | -57.36% | -58.32% | -111.75% | -78.63% | -177.78% | -261.54% | -400.00% | -355.06% | -715.87% |
Total Other Income/Expenses | -230.00K | -199.00K | -173.00K | -172.00K | -176.00K | -188.00K | -163.00K | -149.00K | -109.00K | -105.00K | -119.00K | -117.00K | -122.00K | -160.00K | -112.00K | -9.00K | 12.00K | -3.00K | 3.00K | 14.00K | 29.00K | 100.00K | 100.00K | 100.00K | -38.00K | 10.00K |
Income Before Tax | -1.28M | -1.15M | -978.00K | -794.00K | -210.00K | -1.34M | -2.10M | -2.52M | -3.60M | -3.10M | -2.22M | -2.20M | -1.52M | -1.51M | -2.13M | -2.56M | -2.21M | -2.02M | -1.77M | -2.77M | -2.40M | -3.10M | -3.30M | -3.90M | -2.88M | -2.70M |
Income Before Tax Ratio | -72.18% | -46.17% | -43.29% | -33.11% | -4.93% | -27.00% | -35.79% | -39.77% | -56.13% | -47.56% | -31.00% | -32.39% | -24.18% | -24.10% | -37.77% | -48.96% | -53.05% | -57.45% | -58.22% | -111.19% | -77.69% | -172.22% | -253.85% | -390.00% | -359.80% | -713.23% |
Income Tax Expense | 0.00 | -1.00K | -12.00K | -9.00K | -51.00K | -74.00K | -100.00K | -142.00K | -135.00K | -144.00K | -111.00K | -102.00K | -103.00K | -45.00K | -142.00K | -6.00K | -23.00K | -23.00K | -22.00K | -19.00K | -4.00K | -200.00K | 0.00 | 900.00K | 17.00K | 691.00K |
Net Income | -1.28M | -1.15M | -966.00K | -785.00K | -159.00K | -1.26M | -2.00M | -2.38M | -3.46M | -2.95M | -2.11M | -2.09M | -1.42M | -1.47M | -1.99M | -2.56M | -2.19M | -1.99M | -1.75M | -2.75M | -2.39M | -2.90M | -3.30M | -3.90M | -2.88M | -2.70M |
Net Income Ratio | -72.18% | -46.13% | -42.76% | -32.74% | -3.74% | -25.51% | -34.09% | -37.53% | -54.02% | -45.35% | -29.45% | -30.88% | -22.54% | -23.38% | -35.25% | -48.84% | -52.50% | -56.79% | -57.50% | -110.43% | -77.56% | -161.11% | -253.85% | -390.00% | -359.80% | -713.23% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 | -0.03 | -0.02 | -0.04 | -0.05 | -0.08 | -0.09 | -0.11 | -0.08 | -0.08 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 | -0.03 | -0.02 | -0.04 | -0.05 | -0.08 | -0.09 | -0.11 | -0.08 | -0.08 |
Weighted Avg Shares Out | 1.18B | 685.49M | 580.71M | 526.45M | 509.68M | 471.46M | 301.12M | 270.44M | 216.74M | 194.51M | 164.18M | 148.24M | 136.70M | 129.56M | 105.40M | 96.85M | 87.74M | 74.18M | 70.37M | 63.40M | 50.80M | 36.90M | 36.90M | 35.69M | 35.69M | 35.69M |
Weighted Avg Shares Out (Dil) | 1.18B | 685.49M | 580.71M | 526.45M | 509.68M | 471.46M | 301.12M | 270.44M | 216.74M | 194.51M | 164.18M | 148.24M | 136.70M | 129.56M | 105.40M | 96.85M | 87.74M | 74.18M | 70.37M | 63.40M | 50.80M | 36.90M | 36.90M | 35.69M | 35.69M | 35.69M |
Deltex Medical slips despite chairman optimism
Source: https://incomestatements.info
Category: Stock Reports